Joel Collier

The Collier Lab designs biomaterials for a range of biomedical applications, with a focus on understanding and controlling adaptive immune responses.  Most materials investigated are created from molecular assemblies- proteins, peptides or bioconjugates that self-organize into useful structures such as nanofibers, gels, and particles. 

These biomaterials are being developed as novel treatments for infectious diseases, cancer, wound healing, and chronic inflammation.  Additionally, as these strategies are developed, basic insights into how materials engage the immune system are uncovered.